These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 15518540

  • 1. Atomic mapping of the interactions between the antiviral agent cyanovirin-N and oligomannosides by saturation-transfer difference NMR.
    Sandström C, Berteau O, Gemma E, Oscarson S, Kenne L, Gronenborn AM.
    Biochemistry; 2004 Nov 09; 43(44):13926-31. PubMed ID: 15518540
    [Abstract] [Full Text] [Related]

  • 2. NMR study of hydroxy protons of di- and trimannosides, substructures of Man-9.
    Hakkarainen B, Kenne L, Lahmann M, Oscarson S, Sandström C.
    Magn Reson Chem; 2007 Dec 09; 45(12):1076-80. PubMed ID: 18044811
    [Abstract] [Full Text] [Related]

  • 3. Atomic mapping of the sugar interactions in one-site and two-site mutants of cyanovirin-N by NMR spectroscopy.
    Sandström C, Hakkarainen B, Matei E, Glinchert A, Lahmann M, Oscarson S, Kenne L, Gronenborn AM.
    Biochemistry; 2008 Mar 25; 47(12):3625-35. PubMed ID: 18311923
    [Abstract] [Full Text] [Related]

  • 4. Potent inhibition of HIV-1 fusion by cyanovirin-N requires only a single high affinity carbohydrate binding site: characterization of low affinity carbohydrate binding site knockout mutants.
    Chang LC, Bewley CA.
    J Mol Biol; 2002 Apr 19; 318(1):1-8. PubMed ID: 12054763
    [Abstract] [Full Text] [Related]

  • 5. Site-specific discrimination by cyanovirin-N for alpha-linked trisaccharides comprising the three arms of Man(8) and Man(9).
    Bewley CA, Kiyonaka S, Hamachi I.
    J Mol Biol; 2002 Sep 27; 322(4):881-9. PubMed ID: 12270721
    [Abstract] [Full Text] [Related]

  • 6. A solution NMR study of the interactions of oligomannosides and the anti-HIV-1 2G12 antibody reveals distinct binding modes for branched ligands.
    Enríquez-Navas PM, Marradi M, Padro D, Angulo J, Penadés S.
    Chemistry; 2011 Feb 01; 17(5):1547-60. PubMed ID: 21268157
    [Abstract] [Full Text] [Related]

  • 7. Computational study of the dynamics of mannose disaccharides free in solution and bound to the potent anti-HIV virucidal protein cyanovirin.
    Margulis CJ.
    J Phys Chem B; 2005 Mar 03; 109(8):3639-47. PubMed ID: 16851402
    [Abstract] [Full Text] [Related]

  • 8. Dissecting carbohydrate-Cyanovirin-N binding by structure-guided mutagenesis: functional implications for viral entry inhibition.
    Barrientos LG, Matei E, Lasala F, Delgado R, Gronenborn AM.
    Protein Eng Des Sel; 2006 Dec 03; 19(12):525-35. PubMed ID: 17012344
    [Abstract] [Full Text] [Related]

  • 9. Identification and characterization of peptides that bind to cyanovirin-N, a potent human immunodeficiency virus-inactivating protein.
    Han Z, Simpson JT, Fivash MJ, Fisher R, Mori T.
    Peptides; 2004 Apr 03; 25(4):551-61. PubMed ID: 15165709
    [Abstract] [Full Text] [Related]

  • 10. Selective interactions of the human immunodeficiency virus-inactivating protein cyanovirin-N with high-mannose oligosaccharides on gp120 and other glycoproteins.
    Shenoy SR, O'Keefe BR, Bolmstedt AJ, Cartner LK, Boyd MR.
    J Pharmacol Exp Ther; 2001 May 03; 297(2):704-10. PubMed ID: 11303061
    [Abstract] [Full Text] [Related]

  • 11. Solution structure of a cyanovirin-N:Man alpha 1-2Man alpha complex: structural basis for high-affinity carbohydrate-mediated binding to gp120.
    Bewley CA.
    Structure; 2001 Oct 03; 9(10):931-40. PubMed ID: 11591348
    [Abstract] [Full Text] [Related]

  • 12. Analysis of sequence requirements for biological activity of cyanovirin-N, a potent HIV (human immunodeficiency virus)-inactivating protein.
    Mori T, Shoemaker RH, Gulakowski RJ, Krepps BL, McMahon JB, Gustafson KR, Pannell LK, Boyd MR.
    Biochem Biophys Res Commun; 1997 Sep 08; 238(1):218-22. PubMed ID: 9299482
    [Abstract] [Full Text] [Related]

  • 13. Epitope mapping of sialyl Lewis(x) bound to E-selectin using saturation transfer difference NMR experiments.
    Rinnbauer M, Ernst B, Wagner B, Magnani J, Benie AJ, Peters T.
    Glycobiology; 2003 Jun 08; 13(6):435-43. PubMed ID: 12626392
    [Abstract] [Full Text] [Related]

  • 14. Exploiting Uniformly 13C-Labeled Carbohydrates for Probing Carbohydrate-Protein Interactions by NMR Spectroscopy.
    Nestor G, Anderson T, Oscarson S, Gronenborn AM.
    J Am Chem Soc; 2017 May 03; 139(17):6210-6216. PubMed ID: 28406013
    [Abstract] [Full Text] [Related]

  • 15. Solution structure of cyanovirin-N, a potent HIV-inactivating protein.
    Bewley CA, Gustafson KR, Boyd MR, Covell DG, Bax A, Clore GM, Gronenborn AM.
    Nat Struct Biol; 1998 Jul 03; 5(7):571-8. PubMed ID: 9665171
    [Abstract] [Full Text] [Related]

  • 16. Properties of cyanovirin-N (CV-N): inactivation of HIV-1 by sessile cyanovirin-N (sCV-N).
    Gandhi MJ, Boyd MR, Yi L, Yang GG, Vyas GN.
    Dev Biol (Basel); 2000 Jul 03; 102():141-8. PubMed ID: 10794101
    [Abstract] [Full Text] [Related]

  • 17. Crystal structure of cyanovirin-N, a potent HIV-inactivating protein, shows unexpected domain swapping.
    Yang F, Bewley CA, Louis JM, Gustafson KR, Boyd MR, Gronenborn AM, Clore GM, Wlodawer A.
    J Mol Biol; 1999 May 07; 288(3):403-12. PubMed ID: 10329150
    [Abstract] [Full Text] [Related]

  • 18. A monovalent mutant of cyanovirin-N provides insight into the role of multiple interactions with gp120 for antiviral activity.
    Fromme R, Katiliene Z, Giomarelli B, Bogani F, Mc Mahon J, Mori T, Fromme P, Ghirlanda G.
    Biochemistry; 2007 Aug 14; 46(32):9199-207. PubMed ID: 17636873
    [Abstract] [Full Text] [Related]

  • 19. A model for cell-surface-exposed carbohydrate moieties suitable for structural studies by NMR spectroscopy.
    Mares J, Müller JU, Skirgailiene A, Neumoin A, Bewley CA, Schmidt RR, Zerbe O.
    Chembiochem; 2006 Nov 14; 7(11):1764-73. PubMed ID: 16952190
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.